![Shadow of Brexit feature](https://pharmaphorum.com/wp-content/uploads/2019/03/Shadow-of-Brexit-feature-1.jpg)
MHRA publishes guidance on medicine regulation after Brexit
The UK’s medicines regulator has published long-awaited guidance on regulation of medicines and medical devices as the UK approaches the end of its Brexit transition period at the end of th